What is Smith & Wesson Brands Inc's earnings per share (EPS)?

Smith & Wesson Brands Inc (SWBI) reported diluted earnings per share of $0.41 for fiscal year 2026. This represents a 36.7% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Smith & Wesson Brands Inc (SWBI) Financials

SWBI

Trailing 12 months to July 31, 2026

Revenue $551.4M +17.0% YoY

Net Income $24.5M +106.3% YoY

EPS (Diluted) $0.54 +107.7% YoY

Free Cash Flow $82.1M +1536.9% YoY

Market Cap $550.2M as of Sep 3, 2026

Price / Sales 1.0x on $551.4M revenue, trailing 12 months to July 31, 2026

Price / Earnings 22.5x on $24.5M net income, trailing 12 months to July 31, 2026

Price / Book 1.5x on $373.7M equity, Q1 FY2027

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 3, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q1 FY2027, ended Jul 31, 2026 Reported Sep 3, 2026 Currency USD FYE April

Newest figures come from the 10-Q for Q1 FY2027, filed Sep 3, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the SWBI SEC filings page.

Smith & Wesson Brands Inc (SWBI) reported $551.4M in revenue over the twelve months to Jul 31, 2026, up 17.0% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI SWBI FY2026 2026-09-03

The business is driven by cyclical earnings, while cash generation depends heavily on capital-spending timing.

In FY2026, operating cash flow was 6.2x net income, and free cash flow represented 17.3% of revenue after capital spending; that gap indicates working-capital or non-cash effects materially boosted cash beyond reported profit. This contrasts with FY2025, when operating cash flow and free cash flow were negative, showing cash output is less stable than reported earnings.

Revenue rebounded to $524M in FY2026, but operating margin reached only 5.6%. With gross margin nearly unchanged from FY2025, the improvement points more to partial fixed-cost absorption than a major product-mix shift.

Liabilities fell from $187M in FY2025 to $136M in FY2026, reducing balance-sheet leverage rather than funding the rebound through added obligations. A current ratio above 3.0x indicates substantial reported short-term liquidity, even as cash-flow outcomes swung.

Financial Health Signals

Financial Health Score 55/100

Scored against operating companies for FY2026. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Smith & Wesson Brands Inc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Smith & Wesson Brands Inc has an operating margin of 5.6%, meaning the company retains $6 of operating profit per $100 of revenue. This results in a moderate score of 51/100, indicating healthy but not exceptional operating efficiency. This is up from 5.0% the prior year.

Growth

Smith & Wesson Brands Inc's revenue grew 10.4% year-over-year to $523.8M, a solid pace of expansion. This earns a growth score of 27/100.

Leverage

Smith & Wesson Brands Inc carries a low D/E ratio of 0.36, meaning only $0.36 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 66/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

With a current ratio of 3.20, Smith & Wesson Brands Inc holds $3.20 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 81/100.

Cash Flow

Smith & Wesson Brands Inc has a free cash flow margin of 17.3%, earning a moderate score of 56/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns

Smith & Wesson Brands Inc's ROE of 4.9% shows moderate profitability relative to equity, earning a score of 47/100. This is up from 3.6% the prior year.

Altman Z-Score Safe

5.04

Smith & Wesson Brands Inc scores 5.04, well above the 2.99 safe threshold. This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial

6/8

Smith & Wesson Brands Inc passes 6 of 8 computable financial strength tests (1 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.

Earnings Quality Cash-Backed

6.18x

For every $1 of reported earnings, Smith & Wesson Brands Inc generates $6.18 in operating cash flow ($114.2M OCF vs $18.5M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Safe

6.07x

Smith & Wesson Brands Inc earns $6.07 in operating income for every $1 of interest expense ($29.2M vs $4.8M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$112.6M

YoY+32.3%

QoQ-36.9%

5Y CAGR-16.3%

10Y CAGR-5.9%

Smith & Wesson Brands Inc generated $112.6M in revenue in Q1 2027. This represents an increase of 32.3% from the same quarter a year earlier. Against the prior quarter it is down 36.9%.

EBITDA

$11.9M

YoY+117.6%

QoQ-58.8%

5Y CAGR-35.6%

Smith & Wesson Brands Inc's EBITDA was $11.9M in Q1 2027, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 117.6% from the same quarter a year earlier. Against the prior quarter it is down 58.8%.

Net Income

$2.6M

YoY+175.9%

QoQ-84.0%

5Y CAGR-49.3%

10Y CAGR-23.0%

Smith & Wesson Brands Inc reported $2.6M in net income in Q1 2027. This represents an increase of 175.9% from the same quarter a year earlier. Against the prior quarter it is down 84.0%.

EPS (Diluted)

$0.06

YoY+175.0%

QoQ-83.3%

5Y CAGR-47.9%

10Y CAGR-20.8%

Smith & Wesson Brands Inc earned $0.06 per diluted share (EPS) in Q1 2027. This represents an increase of 175.0% from the same quarter a year earlier. Against the prior quarter it is down 83.3%.

Cash & Balance Sheet

Free Cash Flow

-$20.8M

YoY-67.5%

QoQ-129.8%

Smith & Wesson Brands Inc recorded an outflow of $20.8M in free cash flow in Q1 2027, representing a cash shortfall after capex. This represents a decrease of 67.5% from the same quarter a year earlier. Against the prior quarter it is down 129.8%.

Cash & Debt

$18.7M

YoY+4.1%

QoQ-33.7%

5Y CAGR-35.8%

10Y CAGR-21.7%

Smith & Wesson Brands Inc held $18.7M in cash as of Q1 2027; long-term debt is not reported for that period.

Dividends Per Share

$0.13

YoY0.0%

QoQ0.0%

Smith & Wesson Brands Inc paid $0.13 per share in dividends in Q1 2027. That is unchanged from the same quarter a year earlier. It is unchanged from the prior quarter.

Shares Outstanding

45M

YoY+1.1%

QoQ+0.3%

5Y CAGR-1.4%

10Y CAGR-2.2%

Smith & Wesson Brands Inc had 45M shares outstanding in Q1 2027. This represents an increase of 1.1% from the same quarter a year earlier. Against the prior quarter it is up 0.3%.

Margins & Returns

Gross Margin

28.7%

YoY+2.7pp

QoQ-1.1pp

5Y CAGR-18.7pp

10Y CAGR-13.6pp

Smith & Wesson Brands Inc's gross margin was 28.7% in Q1 2027, indicating the percentage of revenue retained after direct costs. This is up 2.7 percentage points from the same quarter a year earlier. Against the prior quarter it is down 1.1 percentage points.

Operating Margin

3.8%

YoY+7.2pp

QoQ-8.2pp

5Y CAGR-32.6pp

Smith & Wesson Brands Inc's operating margin was 3.8% in Q1 2027, reflecting core business profitability. This is up 7.2 percentage points from the same quarter a year earlier. Against the prior quarter it is down 8.2 percentage points.

Net Margin

2.3%

YoY+6.3pp

QoQ-6.8pp

5Y CAGR-25.7pp

10Y CAGR-14.7pp

Smith & Wesson Brands Inc's net profit margin was 2.3% in Q1 2027, showing the share of revenue converted to profit. This is up 6.3 percentage points from the same quarter a year earlier. Against the prior quarter it is down 6.8 percentage points.

Return on Equity

0.7%

YoY+1.6pp

QoQ-3.6pp

5Y CAGR-24.9pp

10Y CAGR-9.7pp

Smith & Wesson Brands Inc's ROE was 0.7% in Q1 2027, measuring profit generated per dollar of shareholder equity. This is up 1.6 percentage points from the same quarter a year earlier. Against the prior quarter it is down 3.6 percentage points.

Capital Allocation

R&D Spending

$2.6M

YoY-15.0%

QoQ+4.3%

5Y CAGR+7.2%

Smith & Wesson Brands Inc invested $2.6M in research and development in Q1 2027. This represents a decrease of 15.0% from the same quarter a year earlier. Against the prior quarter it is up 4.3%.

Capital Expenditures

$11.9M

YoY+178.0%

QoQ+146.8%

5Y CAGR+15.6%

10Y CAGR-2.8%

Smith & Wesson Brands Inc invested $11.9M in capex in Q1 2027, funding long-term assets and infrastructure. This represents an increase of 178.0% from the same quarter a year earlier. Against the prior quarter it is up 146.8%.

Share Buybacks

Not reported for Q1 2027.

SWBI Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

SWBI quarterly income statement

Metric	TTM	FY2610-K	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K
Revenue	$551.4M	$523.8M+10.4%	$474.7M-11.4%	$535.8M+11.8%	$479.2M-44.5%	$864.1M-18.4%	$1.1B+100.0%	$529.6M+10.0%	$481.3M-20.7%	$606.9M-32.8%	$903.2M+24.9%	$722.9M+31.0%	$551.9M-11.9%	$626.6M+6.7%	$587.5M+42.6%	$412.0M
Cost of Revenue	$400.1M	$382.7M+10.1%	$347.5M-8.0%	$377.7M+16.3%	$324.7M-33.7%	$489.6M-19.8%	$610.2M+67.7%	$363.9M+8.6%	$335.1M-18.5%	$411.1M-22.1%	$527.9M+23.0%	$429.1M+20.2%	$356.9M-2.9%	$367.5M-0.5%	$369.4M+30.0%	$284.1M
Gross Profit	$151.3M	$141.1M+10.9%	$127.2M-19.6%	$158.1M+2.3%	$154.5M-58.7%	$374.6M-16.6%	$449.0M+171.0%	$165.7M+13.3%	$146.3M-25.3%	$195.8M-47.8%	$375.3M+27.7%	$293.8M+50.7%	$194.9M-24.8%	$259.1M+18.8%	$218.1M+70.5%	$127.9M
R&D Expenses	$9.9M	$10.3M+7.7%	$9.6M+31.8%	$7.3M-3.9%	$7.5M+4.0%	$7.3M-2.9%	$7.5M+1.6%	$7.4M-8.0%	$8.0M-29.5%	$11.4M+11.0%	$10.2M+2.3%	$10.0M+44.1%	$6.9M+22.9%	$5.6M+17.9%	$4.8M+5.4%	$4.5M
SG&A Expenses	$62.0M	$60.0M+9.2%	$54.9M-13.0%	$63.1M+2.5%	$61.6M-15.1%	$72.5M-8.5%	$79.3M+20.0%	$66.0M-1.5%	$67.1M-33.9%	$101.5M-12.3%	$115.8M+39.6%	$82.9M+33.0%	$62.3M-9.6%	$69.0M+37.0%	$50.3M+6.8%	$47.1M
Operating Income	$36.4M	$29.2M+22.3%	$23.9M-49.3%	$47.1M-2.7%	$48.4M-80.8%	$251.7M-21.3%	$319.6M+535.4%	$50.3M+15.6%	$43.5M+60.9%	$27.0M-86.5%	$199.9M+26.0%	$158.6M+77.0%	$89.6M-40.6%	$151.0M+13.7%	$132.8M+195.7%	$44.9M
EBITDA	N/A	$60.5M+8.6%	$55.7M-30.0%	$79.7M-0.2%	$79.8M-71.7%	$281.7M-19.8%	$351.2M+326.9%	$82.3M+13.4%	$72.6M-8.3%	$79.1M-68.4%	$250.2M+25.2%	$199.9M+65.8%	$120.5M-30.2%	$172.7M+15.5%	$149.6M+147.6%	$60.4M
Interest Expense	$3.9M	$4.8M+4.1%	$4.6M+124.9%	$2.1M+520.8%	$331K-84.5%	$2.1M-45.5%	$3.9M-66.3%	$11.6M+18.7%	$9.8M-12.3%	$11.2M+30.1%	$8.6M-37.4%	$13.7M+21.0%	$11.3M-7.6%	$12.3M+112.1%	$5.8M-22.8%	$7.5M
Income Tax	$8.7M	$6.6M+13.2%	$5.8M-43.8%	$10.4M-8.8%	$11.3M-80.4%	$57.9M-22.2%	$74.4M+545.7%	$11.5M+24.1%	$9.3M+469.7%	-$2.5M-104.0%	$63.5M+24.1%	$51.1M+76.9%	$28.9M-39.9%	$48.1M+3.4%	$46.5M+269.6%	$12.6M
Net Income	$24.5M	$18.5M+37.7%	$13.4M-67.5%	$41.4M+12.2%	$36.9M-81.0%	$194.5M-22.8%	$252.0M+511.6%	-$61.2M-432.6%	$18.4M-8.5%	$20.1M-84.3%	$127.9M+36.1%	$94.0M+89.4%	$49.6M-44.4%	$89.3M+13.5%	$78.7M+388.7%	$16.1M
EPS (Basic)	N/A	$0.42+40.0%	$0.30-66.7%	$0.90+12.5%	$0.80-80.6%	$4.12-10.8%	$4.62+516.2%	-$1.11-426.5%	$0.34-8.1%	$0.37-83.8%	$2.29+33.1%	$1.72+87.0%	$0.92-39.5%	$1.52+25.6%	$1.21+384.0%	$0.25
EPS (Diluted)	$0.54	$0.41+36.7%	$0.30-66.3%	$0.89+11.2%	$0.80-80.4%	$4.08-10.3%	$4.55+513.6%	-$1.10-433.3%	$0.33-10.8%	$0.37-83.6%	$2.25+33.9%	$1.68+86.7%	$0.90-39.6%	$1.49+26.3%	$1.18+372.0%	$0.25
Diluted Shares (Avg)	N/A	44,9330.0%	44,932-2.8%	46,248+0.2%	46,170-99.9%	48M-13.8%	55M-0.6%	56M+0.8%	55M+0.7%	55M-3.6%	57M+1.7%	56M+1.3%	55M-8.1%	60M-9.8%	67M-0.9%	67M

Metric	Q1'2710-Q	Q4'2610-Q	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q
Revenue	$112.6M+32.3%	$178.4M+26.7%	$135.7M+17.1%	$124.7M-3.9%	$85.1M-3.7%	$140.8M-11.6%	$115.9M-15.7%	$129.7M+3.8%
Cost of Revenue	$80.3M+27.5%	$125.3M+25.0%	$100.1M+13.9%	$94.3M-0.9%	$63.0M-1.8%	$100.2M-2.4%	$87.9M-10.3%	$95.2M+2.1%
Gross Profit	$32.3M+46.2%	$53.1M+30.9%	$35.6M+27.3%	$30.3M-12.0%	$22.1M-8.7%	$40.5M-28.2%	$27.9M-29.1%	$34.5M+8.6%
R&D Expenses	$2.6M-15.0%	$2.5M+25.0%	$2.4M-15.9%	$2.4M+9.5%	$3.0M+19.6%	$2.0M+11.1%	$2.9M+45.7%	$2.2M+28.8%
SG&A Expenses	$15.3M+15.2%	$17.7M+26.9%	$15.5M+25.1%	$13.5M-11.5%	$13.3M-0.4%	$14.0M-20.3%	$12.4M-22.9%	$15.2M-0.7%
Operating Income	$4.2M+242.6%	$21.3M+62.6%	$6.7M+41.5%	$4.1M-45.4%	-$3.0M-93.8%	$13.1M-52.6%	$4.7M-57.9%	$7.5M+100.0%
EBITDA	$11.9M+117.6%	$28.9M+37.1%	$14.0M+13.0%	$12.1M-22.9%	$5.5M-16.0%	$21.1M-41.3%	$12.3M-32.3%	$15.8M+33.0%
Interest Expense	$298K-75.3%	$693K-7.4%	$1.5M-11.4%	$1.4M-2.4%	$1.2M+64.6%	$748K	$1.7M+80.4%	$1.4M+119.7%
Income Tax	$1.4M+307.1%	$4.6M+22.2%	$1.6M+75.9%	$1.1M-30.4%	-$690K-68.7%	$3.7M-34.6%	$920K-62.2%	$1.6M+104.8%
Net Income	$2.6M+175.9%	$16.2M+87.9%	$3.8M+78.5%	$1.9M-57.8%	-$3.4M-83.9%	$8.6M-69.0%	$2.1M-73.3%	$4.5M+82.0%
EPS (Basic)	$0.06+175.0%	$0.37+94.7%	$0.08+60.0%	$0.04-60.0%	-$0.08-100.0%	$0.19-66.7%	$0.05-70.6%	$0.10+100.0%
EPS (Diluted)	$0.06+175.0%	$0.36+89.5%	$0.08+60.0%	$0.04-60.0%	-$0.08-100.0%	$0.19-66.7%	$0.05-70.6%	$0.10+100.0%
Diluted Shares (Avg)	45M+2.7%	N/A	45M+1.3%	45M-0.4%	44M-2.3%	N/A	44M-3.5%	45M-3.1%

SWBI Balance Sheet

SWBI quarterly balance sheet

Metric	FY2610-K	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K
Total Assets	$512.8M-8.4%	$559.6M-3.1%	$577.4M+6.7%	$541.3M+8.8%	$497.5M+11.4%	$446.4M-38.8%	$729.5M-4.9%	$766.8M+2.9%	$745.1M-5.5%	$788.0M+27.2%	$619.5M+26.2%	$490.9M+28.7%	$381.5M+16.7%	$327.0M+25.0%	$261.7M
Current Assets	$241.4M-12.9%	$277.3M-3.5%	$287.3M-1.6%	$291.9M-10.9%	$327.6M+22.1%	$268.3M-31.8%	$393.5M+31.7%	$298.7M+10.5%	$270.4M-15.1%	$318.4M-4.4%	$333.2M+69.1%	$197.1M-17.6%	$239.2M+4.2%	$229.6M+20.4%	$190.7M
Cash & Equivalents	$28.2M+11.7%	$25.2M-58.5%	$60.8M+13.6%	$53.6M-55.6%	$120.7M+6.8%	$113.0M-9.6%	$125.0M+204.8%	$41.0M-16.1%	$48.9M-20.6%	$61.5M-67.8%	$191.3M+353.0%	$42.2M-38.7%	$68.9M-31.5%	$100.5M+77.2%	$56.7M
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$86.7M+37.7%	$63.0M+13.9%	$55.3M
Accounts Receivable	$40.0M-28.4%	$55.9M-5.4%	$59.1M+7.1%	$55.2M-12.0%	$62.7M-7.0%	$67.4M+10.8%	$60.9M-28.3%	$84.9M+49.8%	$56.7M-47.7%	$108.4M+87.6%	$57.8M+4.5%	$55.3M-1.1%	$55.9M+21.3%	$46.1M-4.6%	$48.3M
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$19.0M0.0%	$19.0M0.0%	$19.0M0.0%	$19.0M0.0%	$19.0M0.0%	$19.0M0.0%	$19.0M-89.6%	$182.3M-4.7%	$191.3M+13.2%	$169.0M+121.4%	$76.4M+1.2%	$75.4M	N/A	N/A	N/A
Total Liabilities	$136.2M-27.2%	$187.2M+5.4%	$177.5M+13.3%	$156.7M+14.4%	$137.0M-23.9%	$180.0M-47.4%	$342.4M+6.2%	$322.3M-0.2%	$322.9M-18.2%	$394.9M+26.7%	$311.7M+5.1%	$296.6M+38.1%	$214.7M+47.4%	$145.7M-2.1%	$148.8M
Current Liabilities	$75.4M+13.1%	$66.6M-29.4%	$94.4M+8.2%	$87.2M-2.0%	$88.9M-29.2%	$125.7M-3.3%	$130.0M+16.8%	$111.3M+10.5%	$100.7M-33.4%	$151.2M+23.4%	$122.6M+51.3%	$81.0M-12.5%	$92.5M+12.0%	$82.6M-0.9%	$83.3M
Non-Current Liabilities	$60.8M-49.5%	$120.5M+45.0%	$83.1M+19.7%	$69.5M+44.7%	$48.0M-11.7%	$54.3M-74.4%	$212.4M+0.6%	$211.1M-5.0%	$222.2M-8.8%	$243.6M+28.8%	$189.1M-12.3%	$215.5M+76.5%	$122.1M+93.6%	$63.1M-3.6%	$65.5M
Total Equity	$376.6M+1.1%	$372.5M-6.9%	$399.9M+4.0%	$384.6M+6.7%	$360.5M+35.3%	$266.4M-31.2%	$387.1M-12.9%	$444.4M+5.3%	$422.1M+7.4%	$393.2M+27.7%	$307.8M+58.4%	$194.4M+16.5%	$166.8M-8.0%	$181.3M+60.7%	$112.8M
Retained Earnings	$373.7M-29.8%	$532.6M-1.8%	$542.4M+3.7%	$523.2M+3.7%	$504.6M+55.2%	$325.2M-4.8%	$341.7M-15.2%	$402.9M+3.5%	$389.1M+5.4%	$369.2M+53.0%	$241.3M+63.8%	$147.4M+50.8%	$97.7M+1058.9%	$8.4M+112.0%	-$70.3M

Metric	Q1'2710-Q	Q4'2610-Q	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q
Total Assets	$523.3M-5.6%	$512.8M-8.4%	$538.0M-7.1%	$548.6M-6.6%	$554.6M-2.9%	$559.6M-3.1%	$578.9M+1.5%	$587.4M+2.5%
Current Assets	$247.5M-10.2%	$241.4M-12.9%	$261.5M-12.4%	$268.5M-12.3%	$275.5M-3.4%	$277.3M-3.5%	$298.7M+8.2%	$306.1M+8.6%
Cash & Equivalents	$18.7M+4.1%	$28.2M+11.7%	$18.4M-31.0%	$22.4M-42.6%	$18.0M-49.4%	$25.2M-58.5%	$26.7M-43.6%	$39.1M-11.5%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Accounts Receivable	$29.7M-28.1%	$40.0M-28.4%	$50.8M-11.5%	$45.8M-13.0%	$41.3M-13.5%	$55.9M-5.4%	$57.4M-5.3%	$52.7M-11.8%
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$19.0M0.0%	$19.0M0.0%	$19.0M0.0%	$19.0M0.0%	$19.0M0.0%	$19.0M0.0%	$19.0M0.0%	$19.0M0.0%
Total Liabilities	$149.6M-21.4%	$136.2M-27.2%	$174.6M-18.7%	$185.4M-15.1%	$190.3M-1.6%	$187.2M+5.4%	$214.8M+10.6%	$218.4M+9.5%
Current Liabilities	$68.4M+29.3%	$75.4M+13.1%	$58.1M-9.1%	$53.9M-30.2%	$52.9M-34.3%	$66.6M-29.4%	$64.0M-25.7%	$77.2M-15.1%
Non-Current Liabilities	$81.2M-40.9%	$60.8M-49.5%	$116.4M-22.8%	$131.5M-6.9%	$137.3M+21.8%	$120.5M+45.0%	$150.8M+39.6%	$141.2M+30.0%
Total Equity	$373.7M+2.6%	$376.6M+1.1%	$363.4M-1.0%	$363.2M-2.2%	$364.4M-4.1%	$372.5M-6.9%	$366.9M-2.5%	$371.5M-0.5%
Retained Earnings	$370.5M-29.2%	$373.7M-29.8%	$363.4M-31.0%	$519.5M-2.2%	$523.4M-1.7%	$532.6M-1.8%	$526.9M+1.3%	$531.0M+2.6%

Not reported in any period shown, so not listed: Inventory, Long-Term Debt.

SWBI Cash Flow Statement

SWBI quarterly cash flow statement

Metric	TTM	FY2610-K	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K
Operating Cash Flow	$113.5M	$114.2M+1681.0%	-$7.2M-106.8%	$106.7M+537.9%	$16.7M-87.9%	$137.8M-56.3%	$315.3M+232.9%	$94.7M+65.9%	$57.1M-7.4%	$61.6M-50.1%	$123.6M-26.7%	$168.6M+46.8%	$114.8M+27.3%	$90.2M-8.0%	$98.1M+162.5%	$37.4M
Depreciation & Amortization	N/A	$31.3M-1.7%	$31.8M-2.2%	$32.6M+3.6%	$31.4M+4.5%	$30.1M-4.8%	$31.6M-1.2%	$32.0M+10.1%	$29.0M-44.2%	$52.1M+3.7%	$50.2M+21.8%	$41.2M+33.5%	$30.9M+42.3%	$21.7M+29.7%	$16.7M+8.0%	$15.5M
Stock-Based Compensation	N/A	$8.3M+9.7%	$7.6M+33.9%	$5.7M+11.4%	$5.1M+12.5%	$4.5M-3.6%	$4.7M+99.7%	$2.4M-66.1%	$6.9M-11.1%	$7.8M-9.0%	$8.6M+32.7%	$6.5M+11.4%	$5.8M-29.3%	$8.2M+101.6%	$4.1M+64.0%	$2.5M
Capital Expenditures	$31.4M	$23.7M+9.9%	$21.6M-76.2%	$90.8M+1.3%	$89.6M+273.6%	$24.0M+8.7%	$22.1M+77.3%	$12.4M-59.7%	$30.9M+67.1%	$18.5M-47.0%	$34.9M+18.3%	$29.5M+4.5%	$28.2M-47.1%	$53.3M+28.6%	$41.4M+200.8%	$13.8M
Free Cash Flow	$82.1M	$90.4M+413.7%	-$28.8M-280.4%	$16.0M+121.9%	-$72.8M-164.0%	$113.8M-61.2%	$293.3M+256.4%	$82.3M+214.1%	$26.2M-39.3%	$43.2M-51.3%	$88.7M-36.2%	$139.1M+60.6%	$86.6M+134.6%	$36.9M-34.9%	$56.7M+140.1%	$23.6M
Investing Cash Flow	-$34.0M	-$28.2M-47.3%	-$19.2M+76.5%	-$81.5M+9.2%	-$89.8M-272.3%	-$24.1M-3.0%	-$23.4M-67.7%	-$14.0M+59.9%	-$34.8M+17.4%	-$42.2M+82.7%	-$243.7M-661.9%	-$32.0M+82.8%	-$186.1M-197.1%	-$62.6M-90.3%	-$32.9M-145.8%	-$13.4M
Financing Cash Flow	-$78.7M	-$83.0M-801.0%	-$9.2M+48.7%	-$18.0M-405.7%	$5.9M+105.5%	-$106.0M+65.1%	-$303.9M-9091.8%	$3.4M+111.1%	-$30.5M+5.3%	-$32.2M-236.3%	-$9.6M-176.6%	$12.5M-72.0%	$44.6M+175.3%	-$59.2M-176.5%	-$21.4M+16.2%	-$25.6M
Dividends Paid	$23.5M	$23.2M+0.6%	$23.1M+4.9%	$22.0M+20.1%	$18.3M+21.9%	$15.0M+82.8%	$8.2M	$0	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	$0-100.0%	$25.5M+149.4%	$10.2M	$0-100.0%	$90.0M-18.2%	$110.0M	$0	N/A	N/A	$50.1M	N/A	$30.0M-74.1%	$115.9M+479.4%	$20.0M	N/A

Metric	Q1'2710-Q	Q4'2610-Q	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q
Operating Cash Flow	-$8.8M-9.1%	$74.6M+82.7%	$20.5M+307.9%	$27.3M+468.6%	-$8.1M+73.7%	$40.8M-6.6%	-$9.8M-139.0%	-$7.4M-157.4%
Depreciation & Amortization	$7.7M-8.7%	$7.6M-4.8%	$7.2M-4.7%	$8.0M-2.2%	$8.4M+4.8%	$8.0M-3.4%	$7.6M+9.1%	$8.2M+1.7%
Stock-Based Compensation	$1.8M-4.2%	N/A	N/A	N/A	$1.9M+2.0%	N/A	N/A	N/A
Capital Expenditures	$11.9M+178.0%	$4.8M-33.7%	$3.6M-42.4%	$11.0M+232.8%	$4.3M-8.7%	$7.3M+30.9%	$6.3M-65.3%	$3.3M-90.5%
Free Cash Flow	-$20.8M-67.5%	$69.7M+108.0%	$16.8M+204.2%	$16.3M+252.1%	-$12.4M+65.1%	$33.5M-12.1%	-$16.1M-329.3%	-$10.7M+71.7%
Investing Cash Flow	-$13.2M-77.3%	-$4.8M+35.4%	-$3.6M+7.7%	-$12.4M-285.7%	-$7.5M-60.0%	-$7.4M-848.9%	-$3.9M+74.6%	-$3.2M+90.8%
Financing Cash Flow	$12.6M+51.6%	-$60.0M-71.9%	-$20.9M-1625.3%	-$10.4M-173.3%	$8.3M-18.2%	-$34.9M-11.8%	$1.4M+120.5%	$14.2M-46.6%
Dividends Paid	$6.0M+1.8%	$5.8M+1.1%	$5.9M+1.6%	$5.9M+1.6%	$5.9M-0.5%	$5.7M+4.7%	$5.8M+5.3%	$5.8M+4.3%
Share Buybacks	N/A	$0	$0-100.0%	$0-100.0%	$0-100.0%	$0-100.0%	$2.8M+210.9%	$9.8M+18.9%

SWBI Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

SWBI quarterly financial ratios

Metric	FY2610-K	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K
Gross Margin	26.9%+0.1pp	26.8%-2.7pp	29.5%-2.8pp	32.3%-11.1pp	43.4%+1.0pp	42.4%+11.1pp	31.3%+0.9pp	30.4%-1.9pp	32.3%-9.3pp	41.5%+0.9pp	40.6%+5.3pp	35.3%-6.0pp	41.3%+4.2pp	37.1%+6.1pp	31.1%
Operating Margin	5.6%+0.6pp	5.0%-3.8pp	8.8%-1.3pp	10.1%-19.0pp	29.1%-1.1pp	30.2%+20.7pp	9.5%+0.5pp	9.0%+4.6pp	4.5%-17.7pp	22.1%+0.2pp	21.9%+5.7pp	16.2%-7.9pp	24.1%+1.5pp	22.6%+11.7pp	10.9%
Net Margin	3.5%+0.7pp	2.8%-4.9pp	7.7%0.0pp	7.7%-14.8pp	22.5%-1.3pp	23.8%+35.4pp	-11.6%-15.4pp	3.8%+0.5pp	3.3%-10.8pp	14.2%+1.2pp	13.0%+4.0pp	9.0%-5.3pp	14.2%+0.8pp	13.4%+9.5pp	3.9%
Return on Equity	4.9%+1.3pp	3.6%-6.7pp	10.3%+0.8pp	9.6%-44.4pp	53.9%-40.7pp	94.6%+110.4pp	-15.8%-20.0pp	4.1%-0.6pp	4.8%-27.7pp	32.5%+2.0pp	30.5%+5.0pp	25.5%-28.0pp	53.5%+10.1pp	43.4%+29.1pp	14.3%
Return on Assets	3.6%+1.2pp	2.4%-4.8pp	7.2%+0.4pp	6.8%-32.3pp	39.1%-17.4pp	56.5%+64.8pp	-8.4%-10.8pp	2.4%-0.3pp	2.7%-13.5pp	16.2%+1.1pp	15.2%+5.1pp	10.1%-13.3pp	23.4%-0.7pp	24.1%+17.9pp	6.2%
Current Ratio	3.20-1.0x	4.16+1.1x	3.04-0.3x	3.35-0.3x	3.68+1.5x	2.13-0.9x	3.03+0.3x	2.680.0x	2.69+0.6x	2.11-0.6x	2.72+0.3x	2.43-0.2x	2.58-0.2x	2.78+0.5x	2.29
Debt-to-Equity	0.36-0.1x	0.50+0.1x	0.440.0x	0.410.0x	0.38-0.3x	0.68-0.2x	0.88+0.2x	0.730.0x	0.76-0.2x	1.000.0x	1.01-0.5x	1.53+0.2x	1.29+0.5x	0.80-0.5x	1.32
Asset Turnover	1.02+0.2x	0.85-0.1x	0.930.0x	0.89-0.9x	1.74-0.6x	2.37+1.6x	0.73+0.1x	0.63-0.2x	0.81-0.3x	1.150.0x	1.170.0x	1.12-0.5x	1.64-0.2x	1.80+0.2x	1.57
FCF Margin	17.3%+23.3pp	-6.1%-9.0pp	3.0%+18.2pp	-15.2%-28.4pp	13.2%-14.5pp	27.7%+12.1pp	15.5%+10.1pp	5.4%-1.7pp	7.1%-2.7pp	9.8%-9.4pp	19.2%+3.5pp	15.7%+9.8pp	5.9%-3.8pp	9.7%+3.9pp	5.7%

Metric	Q1'2710-Q	Q4'2610-Q	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q
Gross Margin	28.7%+2.7pp	29.8%+1.0pp	26.2%+2.1pp	24.3%-2.3pp	25.9%-1.4pp	28.8%-6.7pp	24.1%-4.6pp	26.6%+1.2pp
Operating Margin	3.8%+7.2pp	12.0%+2.6pp	5.0%+0.9pp	3.3%-2.5pp	-3.5%-1.7pp	9.3%-8.1pp	4.1%-4.1pp	5.8%+2.8pp
Net Margin	2.3%+6.3pp	9.1%+3.0pp	2.8%+1.0pp	1.5%-2.0pp	-4.0%-1.9pp	6.1%-11.4pp	1.8%-3.9pp	3.5%+1.5pp
Return on Equity	0.7%+1.6pp	4.3%+2.0pp	1.0%+0.5pp	0.5%-0.7pp	-0.9%-0.5pp	2.3%-4.7pp	0.6%-1.5pp	1.2%+0.6pp
Return on Assets	0.5%+1.1pp	3.2%+1.6pp	0.7%+0.3pp	0.4%-0.4pp	-0.6%-0.3pp	1.5%-3.3pp	0.4%-1.0pp	0.8%+0.3pp
Current Ratio	3.62-1.6x	3.20-1.0x	4.50-0.2x	4.98+1.0x	5.21+1.7x	4.16+1.1x	4.67+1.5x	3.97+0.9x
Debt-to-Equity	0.40-0.1x	0.36-0.1x	0.48-0.1x	0.51-0.1x	0.520.0x	0.50+0.1x	0.59+0.1x	0.59+0.1x
Asset Turnover	0.22+0.1x	0.35+0.1x	0.25+0.1x	0.230.0x	0.150.0x	0.250.0x	0.200.0x	0.220.0x
FCF Margin	-18.4%-3.9pp	39.1%+15.3pp	12.4%+26.3pp	13.1%+21.3pp	-14.6%+25.6pp	23.8%-0.2pp	-13.9%-19.1pp	-8.3%+22.0pp

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Smith & Wesson Brands Inc SWBI	FY2026	$523.8M	$18.5M	3.5%	$550.2M	55/100
Park Aerospace Corp PKE	FY2026	$73.3M	$11K	0.0%	$689.3M	79/100
Tat Techn TATT	FY2025	$178.0M	$16.8M	9.4%	$477.7M	66/100
Byrna Technologies Inc BYRN	FY2025	$118.1M	$9.7M	8.2%	$77.4M	48/100
Satellogic Inc SATL	FY2025	$17.7M	-$4.8M	-27.0%	$707.2M	51/100

Where Smith & Wesson Brands Inc Ranks

Frequently Asked Questions

What is Smith & Wesson Brands Inc's annual revenue?

Smith & Wesson Brands Inc (SWBI) reported $523.8M in total revenue for fiscal year 2026. This represents a 10.4% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Smith & Wesson Brands Inc's revenue growing?

Smith & Wesson Brands Inc (SWBI) revenue grew by 10.4% year-over-year, from $474.7M to $523.8M in fiscal year 2026.

Is Smith & Wesson Brands Inc profitable?

Yes, Smith & Wesson Brands Inc (SWBI) reported a net income of $18.5M in fiscal year 2026, with a net profit margin of 3.5%.

What is Smith & Wesson Brands Inc's EBITDA?

Smith & Wesson Brands Inc (SWBI) had EBITDA of $60.5M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.

What is Smith & Wesson Brands Inc's gross margin?

Smith & Wesson Brands Inc (SWBI) had a gross margin of 26.9% in fiscal year 2026, indicating the percentage of revenue retained after direct costs of goods sold.

What is Smith & Wesson Brands Inc's operating margin?

Smith & Wesson Brands Inc (SWBI) had an operating margin of 5.6% in fiscal year 2026, reflecting the profitability of core business operations before interest and taxes.

What is Smith & Wesson Brands Inc's net profit margin?

Smith & Wesson Brands Inc (SWBI) had a net profit margin of 3.5% in fiscal year 2026, representing the share of revenue converted into profit after all expenses.

Does Smith & Wesson Brands Inc pay dividends?

Yes, Smith & Wesson Brands Inc (SWBI) paid $0.52 per share in dividends during fiscal year 2026.

What is Smith & Wesson Brands Inc's return on equity (ROE)?

Smith & Wesson Brands Inc (SWBI) has a return on equity of 4.9% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.

What is Smith & Wesson Brands Inc's free cash flow?

Smith & Wesson Brands Inc (SWBI) generated $90.4M in free cash flow during fiscal year 2026. This represents a 413.7% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Smith & Wesson Brands Inc's operating cash flow?

Smith & Wesson Brands Inc (SWBI) generated $114.2M in operating cash flow during fiscal year 2026, representing cash generated from core business activities.

What are Smith & Wesson Brands Inc's total assets?

Smith & Wesson Brands Inc (SWBI) had $512.8M in total assets as of fiscal year 2026, including both current and long-term assets.

What are Smith & Wesson Brands Inc's capital expenditures?

Smith & Wesson Brands Inc (SWBI) invested $23.7M in capital expenditures during fiscal year 2026, funding long-term assets and infrastructure.

How much does Smith & Wesson Brands Inc spend on research and development?

Smith & Wesson Brands Inc (SWBI) invested $10.3M in research and development during fiscal year 2026.

How many shares does Smith & Wesson Brands Inc have outstanding?

Smith & Wesson Brands Inc (SWBI) had 45M shares outstanding as of fiscal year 2026.

What is Smith & Wesson Brands Inc's current ratio?

Smith & Wesson Brands Inc (SWBI) had a current ratio of 3.20 as of fiscal year 2026, which is generally considered healthy.

What is Smith & Wesson Brands Inc's debt-to-equity ratio?

Smith & Wesson Brands Inc (SWBI) had a debt-to-equity ratio of 0.36 as of fiscal year 2026, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Smith & Wesson Brands Inc's return on assets (ROA)?

Smith & Wesson Brands Inc (SWBI) had a return on assets of 3.6% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.

What is Smith & Wesson Brands Inc's P/E ratio?

Smith & Wesson Brands Inc (SWBI) trades at 22.5x earnings, its market capitalization divided by net income of $24.5M net income, trailing 12 months to July 31, 2026. The market capitalization is $550.2M as of Sep 3, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Smith & Wesson Brands Inc's price-to-sales ratio?

Smith & Wesson Brands Inc (SWBI) trades at 1.0x sales, its market capitalization divided by revenue of $551.4M revenue, trailing 12 months to July 31, 2026. The market capitalization is $550.2M as of Sep 3, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Smith & Wesson Brands Inc's Altman Z-Score?

Smith & Wesson Brands Inc (SWBI) has an Altman Z-Score of 5.04, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Smith & Wesson Brands Inc's Piotroski F-Score?

Smith & Wesson Brands Inc (SWBI) has a Piotroski F-Score of 6 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Smith & Wesson Brands Inc's earnings high quality?

Smith & Wesson Brands Inc (SWBI) has an earnings quality ratio of 6.18x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Smith & Wesson Brands Inc cover its interest payments?

Smith & Wesson Brands Inc (SWBI) has an interest coverage ratio of 6.07x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Smith & Wesson Brands Inc?

Smith & Wesson Brands Inc (SWBI) scores 55 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.